Connect with us

Advocacy

Italian activists hand in signatures calling for referendum on cannabis and psilocybin

Divorce and abortion legalisation have also been introduced through popular referendums.

Published

on

Referendum: An Italian flag flapping against the breeze

Activists in Italy have handed in over 630,000 signatures calling for a referendum on cannabis and psilocybin mushrooms next year.

In Italy, a popular referendum can be called if a petition secures over 500,000 signatures before the September 30 deadline. Campaigners from several pro-cannabis organisations and political parties managed to gather 500,000 in one week. If the public votes to decriminalise then it would mean the purchase, sale and cultivation of the drug will become legal under Italian law.

The referendum would seek to amend a 1990 law that makes cannabis sales punishable with two to six months in prison. It also makes possession punishable with the suspension of driving licences. Although Italy initially decriminalised recreational cannabis in 1993, a 2006 law introduced penalties on consumers and tripled prison sentences until it was altered in 2014.

Under current law, consumers can be fined and have their personal documents such as a driving licence suspended. 

The campaigners state that legalising cannabis could create thousands of new jobs and increase tax revenue for the state. 

Referendum success

If it is successful, the Supreme Court of Cassation will verify the legitimacy of all signatures while the Constitutional Court ensures the referendum question is in line with the Italian constitution. If all the signatures are validated then the president of Italy, Sergio Mattarella, can establish a date for the referendum. Italian citizens may vote yes to remove the article of narcotic law that criminalise cannabis cultivation for personal use and the penalties for possession.

If it is approved then Italy would become the fourth EU member state to legalise along with Portugal, Czech Republic and Estonia. Italy was one of the first states to legalise medical cannabis in 2007

Referendum: A post from the Cannabis Legale referendum facebook page saying they have 500 signatures

Image rights: Referendumcannabis.it

The campaigners wrote on their Facebook page: “More than 500,000 online signatures in just a week for the #ReferendumCannabis. We celebrate them by thanking you one by one because this is a first and not just in Italy.”

“But now the race continues, to secure this finish line we have very few days to collect many more. So with a smile, we keep sharing, explaining, taking to the streets, discussing because we know exactly what we want: legal cannabis and Italy free from the mafia.”

It is estimated that around 6 million Italians use cannabis. The European Drug Report stated around 1.8 percent of adults in the European Union used cannabis daily. A recent poll has also shown that 47.8 percent of those who participated are in favour of legalising cannabis in Italy. 

Divorce and abortion legalisation in Italy was also achieved through the referendum process.

READ MORE  From alcoholic wine to cannabinoids: one teetotaller's journey to CBD

Cannabis cultivation

Earlier this month, it was announced that Italy could legalise the cultivation of up to four cannabis plants at home as part of reforms approved by the Lower House’s Justice Committee. While it legalised small scale cultivation, the penalties for selling may increase from six to ten years.

Read more about this story here

Speaking with cannabis news about the prospect of cultivation in the home being legalised, Guido Silvestri, a board member for Volt Italia explains the reality of medical cannabis in Italy. Volt is a pan-European party that supports cannabis legalisation in all 30 countries where it is active.

“In principle in Italy, since 2006, doctors have been able to prescribe magisterial preparations containing cannabis-based active substances for medical use. The practice is unfortunately very different and cumbersome for patients.”

“Doctor is never obliged to prescribe this therapy and many refuse even to consider cannabis as a therapeutic option because they do not know it. Even when the patient finds one of the few pharmacies ready to prepare cannabis (only 600 out of 19,000 total in Italy), they will likely experience the continuous cannabis shortage linked to very high demand and little supply.”

He added: “Many patients are therefore forced to buy cannabis on the illegal market or to self-cultivate it, with the risk of criminal investigation and trial, or administrative sanctions. In September, a proposal of law to decriminalise the home cultivation of a limited number of plants was eventually approved by a commission of the Parliament.

He explains that there is already a backlash to the proposals to legalise: “Prohibitionist politicians have announced an avalanche of amendments to immediately and definitively crush the proposal. At this point, about a year and a half after the dissolution of the Houses, there is a high risk that Parliament will not be able to approve a text definitively, leaving patients unprotected and 6 million cannabis consumers in the hands of the Mafia.”

Guido commented on the petition: “Associations like Meglio Legale, Antigone, “Luca Coscioni”, together with few small and new parties, like Volt, Possibile, that supported cannabis legalisation in Italy, decided to try to collect the 500,000 signatures needed to set a referendum that eliminates the crime of cultivation and cancels administrative sanctions. For the first time in Italy, it is possible to collect signatures digitally; this is an innovation introduced only a few weeks ago.”

READ MORE  Lung cancer patient sees tumour shrink by over 70% using cannabis oil

He concluded: “This is likely the consequence of the strong potential of the digital signature and the large distance between the sentiment of the population and the perception of the traditional political parties that seat in the parliament. The Italian population will eventually have the possibility to be informed and vote on cannabis based on facts and not old ideologies.”

Read more: Ryan’s Law could mean that medical cannabis is allowed in hospitals

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advocacy

US Congresswoman speaks out about how cannabis helped her depression

Nancy Mace spoke out about using cannabis to help her depression after experiencing a traumatic event as a teenager

Published

on

Image credit: Nancy Mace/Instagram

A Republican congresswoman who has proposed a federal bill to legalise cannabis has spoken out about her experience using cannabis to combat depression.

Nancy Mace, a republican politician from South Carolina appeared on Fox Business’s ‘Kennedy’ show to talk about the bill which would legalise cannabis but would also focus on veteran access.

It also includes expungement for non-violent cannabis crimes and imposes a revenue tax that would support reinvestment into communities hurt by the war on drugs.

Bill: A banner for always pure organics

The bill titled the States Reform Act would federally legalise and tax cannabis has been proposed ahead of competing Democrat proposed bills. While the bill was originally proposed in July, Mace shared her story after officially filing the State Reform Act in November.

At the end of the discussion, host, Lisa “Kennedy” Montgomery asked the congresswoman if she smoked cannabis.

Nancy replied: “When I was 16, I was raped. I was given prescription medication that made the feelings I had of depression worsen, and I stopped taking those prescription drugs and I turned to cannabis for a brief period of time in my life.”

She added that she believed her experience with cannabis made her more sympathetic to veterans who may use cannabis for conditions such as post-traumatic stress disorder (PTSD).

Bill protection for veterans

The congresswoman explained that the new bill is “particularity protective of veterans, ensuring they are protected, not discriminated against and that the US Department of Veteran Affairs can utilise cannabis for their PTSD.”

READ MORE  "I was sceptical about cannabis, now I help others overcome stigma"

She added: “When I talk to vets and I see that pain, it hurts because I felt that pain before in my life. Veteran suicide, we see every single day.”

One other provision in the bill is that cannabis would be under the Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB) instead of the Food and Drug Administration (FDA). The FDA would have some involvement similar to its current control over the alcohol industry.

Bill history

Mace has already won an exception for rape and incest victims in a fatal fetal heartbeat bill. She mentioned her history when it came to proposing that bill in 2019.

She said: “I’ve had family that have overdosed from hardcore opiates and prescription drugs. And I’ve mentioned part of this in 2019, at the time I got the exception for rape and incest in the fetal-heartbeat bill I told my story about being raped when I was 16, but I’ve never said this part publicly before: I was prescribed antidepressants afterwards, and it made my feelings a lot worse. And so I started using cannabis for a brief moment, for a time in my life. It helped me. It cut down on my anxiety and helped me get through some dark periods.”

 

Fibromyalgia: A banner advert for cannabis health news

Continue Reading

Advocacy

First patient set to receive cannabis products on Ireland’s MCAP programme

CannEpil is the first drug available through the programme but has yet to be prescribed

Published

on

Ireland HSE offer medical cannabis
CannEpil was announced as the first drug to be made available through the programme

Earlier this year, the Irish Health Service Executive (HSE) has announced that the first cannabis-based products will be available through the Medical Cannabis Access Programme from mid-October.

Despite an update from the Irish health service (HSE) and Health Products Regulatory Authority (HPRA) that CannEpil would be prescribed by the middle of October, the first prescription has been delayed.

People before Profit TD for Dublin Mid-West Gino Kenny tweeted that the first prescription should be available from next week.

The HSE has yet to confirm that the products will be available from next week but says they would not be aware until the consultant neurologist has issued claims at the end of the month.

In a statement to Cannabis Health News, a press officer at the HSE stated: “The HSE has registered three patients under the MCAP in recent days. We would not be aware whether the consultant neurologist has proceeded with prescribing for an individual until claims were submitted from pharmacies at the end of the month.”

He also raised the issue in the Dáil earlier this month to Taoiseach, Michael Martin.

“Many families would have been very joyous during the summer when the medical cannabis access programme was to commence. But sadly, in a PQ response today, not one patient has been given access thus far. That is a huge disappointment to those families that this treatment could make life-changing benefits,” he said.

READ MORE  Cannabis sector unites to demand 'real change'

“So what do you say to families that feel let down by the program and now they have to look at other treatments and probably getting no treatment at all?” He asked.

Michael Martin replied that a lot of patients have been facilitated by the original ‘imported license’ but he was unsure as to why patients had not availed of the MCAP. He promised to follow up with the Minister for Health, Stephen Donnelly of Fianna Fáil.

Gino announced changes to the Cannabis Regulation and Control bill that he is due to submit. It will now take place next year with a focus on production and consumption for personal use.

HSE committee meeting

In a joint committee meeting held in September, CannEpil was announced as the first drug to be made available through the program from mid-October.

Ireland’s Health minister Stephen Donnelly announced funding for the Medical Cannabis Access Programme (MCAP) in January, almost two years since the legislation was signed off in June 2019.

The programme will offer access to cannabis-based medicines to people living with one of three qualifying conditions. These include intractable nausea and vomiting associated with chemotherapy, severe treatment-resistant epilepsy and spasticity associated with multiple sclerosis (MS) where patients have failed to respond to authorised treatments.

The meeting saw officials from the Department of Health and the Health Products Regulatory Authority (HPRA) outline the current state of the MCAP programme and the Ministerial License system.

READ MORE  Why do athletes use CBD?

The suppliers of two products, CannEpil and Tilray are said to have confirmed their prices to the HSE, but Tilray has yet to announce its availability date.  Two more cannabis-based products have been added to the schedule but suppliers are not thought to have current plans to supply the Irish market.

Morris O’Connor, the assistant national director of primary care reimbursement, announced that two additional products were expected to be added to the schedule in the coming weeks and that the programme may be extended for longer than the initial five year pilot period.

He stated: “There are currently four cannabis products on the schedule and two more to be added to schedule one of the regulations in the coming weeks. I understand that one of the products in the schedule namely CannEpil is expected to be available in October, subsequent to the introduction of the necessary legislation.”

According to Lorraine Nolan the chief executive of HPRA, since the MCAP regulations came into force in June 2019, 34 applications have been made for cannabis-based products.

Of these four cannabis oils have been placed in schedule one of the regulations, and two dry herb products have completed the final HPRA review and are awaiting a ministerial decision. Five are currently under active review.

Nolan commented: “The first cannabis-based products are expected to be made available to Irish patients through MCAP in October 2021. Once these are accessed by Irish patients, the HPRA will receive any reports of suspected adverse events and review them for any signals of concern regarding the safety of the product.

READ MORE  From alcoholic wine to cannabinoids: one teetotaller's journey to CBD

“The HPRA will also have a role in investigating any quality issues that may arise and coordinate any action that might be subsequently required.”

Doctors are asked to register patients who may benefit from this treatment to the HSE including the condition they are being prescribed for.

The HPRA will be monitoring patients for adverse effects over the coming weeks once the medication is available.

The MCAP programme has been criticised by patients who are still waiting for access to products despite the introduction of the scheme in 2019 under then Minister for Health, Simon Harris.

O’Conner also highlighted that 192 ministerial licenses have already been issued for 67 individuals who access medication from the Netherlands.

In July a direct funding scheme was announced to remove the need for patients to pay for these prescriptions up front and then apply for reimbursement from the Government.

Continue Reading

Advocacy

Irish politicians receive cannabis in mail to mark National Legalise Cannabis day

The letters outlined the reasons why legalising cannabis in Ireland needs to be a top priority for government officials.

Published

on

Irish: A banner advert for National Legalise cannabis day

Two hundred Irish TDs received a letter outlining the reasons for cannabis legalisation and a roll-up in the post sparking an investigation

The cannabis was sent by An Póst by leading cannabis activists to mark National Legalise Cannabis Day in Ireland. The cannabis was accompanied by a letter outlining ten reasons why cannabis should be legalised and made accessible. Cannabis activists including Cannabis Activist Alliance, ReLeaf CBD Café, and Martin Condon from the podcast Martin’s World shared images of the letters online before sending them to ministers.

Two hundred letters containing cannabis roll-ups and edibles were sent to ministers including the President of Ireland, Michael D Higgins. A further forty were sent to members of the media and senators. Mary Lou McDonald of Sinn Fein was even sent a tricolour roll-up.

In a statement online, those involved encouraged other cannabis consumers and activists to get involved in the action.

“To mark the 20th anniversary of this event the Martins World Podcast, The Cannabis Activist Alliance and the ReLeaf Cafe have teamed up to recreate this event. Cannabis containing joints will again be posted to every TD and Senator in Ireland. With the joint, we will include a letter about the campaign and 10 reasons why Cannabis prohibition should be ended (there are thousands to choose from). We encourage anyone who wants to get involved to do so. It will only cost you the price of a stamp and envelope.”

Some of the benefits listed in the letters included the creation of jobs, open access for patients and researchers, the end to the discrimination faced by patients and also the protection of minors with the introduction of regulation.

READ MORE  Medical cannabis and pain – new findings

Irish cannabis market

While the letter highlighted the reasons why cannabis should be legalised in Ireland, it also gave a stern warning about the dangers of buying cannabis from an unregulated market.

“As this product was sourced from an unregulated market, you as a consumer have very little protection. There is no guarantee that this joint contains any cannabis. If it does contain cannabis you as a consumer have no idea as to the potency of the cannabis. This makes dosing incredibly difficult and could put you at risk.”

The action has sparked an investigation by Irish authorities after scanners at the ministerial buildings failed to recognise the substance. It was reported that nearly all of the Green party received a letter along with members of Fianna Fáil and Fine Gael.

Irish ministers response

Most of the ministers have not confirmed if they have or have not received the letters. However, Cathal Crowe, a Fianna Fáil TD for Clare posted a photo of the letter on Twitter confirming he had received one.

Irish Green party councillor, Oliver Moran also received a letter and tweeted his response. “Many thanks for including me in this action—and for the prudent warning that potency and content are unknown when drugs are purchased from an underground market.”

November 5 was declared  National Legalise Cannabis Day by Independent TD, Luke Ming Flanagan back in 2001. The letters campaign was created to mark the 20th anniversary of this.

READ MORE  Almost half of THC-dominant cannabis flowers mislabelled

Ireland’s cannabis reform

The campaign comes amidst criticism that the Medical Cannabis Access Programme is still not functioning despite reassurances that Cannephil would be available from mid-October.

People before Profit TD for Dublin Mid-West, Gino Kenny raised the issue in the Dáil to Taoiseach, Michael Martin.

“Many families would have been very joyous during the summer when the medical cannabis access programme was to commence. But sadly, in a PQ response today, not one patient has been given access thus far. That is a huge disappointment to those families that this treatment could make life-changing benefits,” he said.

He added: “So what do you say to families that feel let down by the program and now they have to look at other treatments and probably getting no treatment at all?”

Michael Martin replied by saying that a lot of patients have been facilitated by the original ‘imported license’ but was unsure as to why patients had not availed of the MCAP. He promised to follow up with the Minister for Health which is currently Stephen Donnelly of Fianna Fáil.

Gino also announced changes to the Cannabis Regulation and Control bill that he is due to submit. It will now take place next year with a focus on production and consumption for personal use.

Image credit : Martin’sWorld

READ MORE  MS patients denied access to “life-changing” cannabis drug

Irish: A banner advertising a competition

Continue Reading

Trending